Paolo A. Ascierto, MD

Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Tumor Institute Fondazione G. Pascale, Naples, Italy

Paolo A. Ascierto, MD, is Vice-Director of the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy at the National Tumor Institute Fondazione G. Pascale in Naples (Italy). He earned his medical degree from the University of Naples, where he earned board certification in oncology. Before the present position he previously served there as a postdoctoral fellow and then vice director of the Department of Clinical Immunology. Moreover, he was the Director of the Unit of Medical Oncology and Innovative Therapy in the period April 2008- July 2011. Major research interests have included genetics and proteomics research of melanoma, apoptosis and cell death in human cancer, assessment of new molecular markers for tumor progression in patients with malignant melanoma, as well as targeted therapies for melanoma, biochemical and immunological monitoring, and vaccination treatments. He has served as principal investigator in numerous clinical trials and has been well-published in peer-reviewed journals on topics related to his interests. Dr. Ascierto serves on the editorial boards of the Journal of Translational Medicine, the Combination Products in Therapy, the Journal of Skin Cancer, the Journal of Molecular Biomarkers & Diagnosis, Dataset Papers in Medicine, The Journal of OncoPathology, and the Annals of Translational Medicine. He is the Editor in Chief of the Combination Strategies section of the Journal of Translational Medicine. He has been an invited speaker at more than 200 national and international meetings, and maintains active memberships in several medical societies in Italy and abroad.